David Hamilton at Venture Beat covers the latest events at CIRM, the California Institute for Regenerative Medicine. While the $3 billion stem cell program has started disbursing funds to scientists, bad news continues to hound the endeavor. Most recently, Arlene Chiu, the interim chief scientific officer, resigned unexpectedly, Hamilton writes. Her departure follows on the heels of the resignation earlier this year of Zach Hall, CIRM's first president. Since then, the institute has had trouble filling its top position, and recently announced that Richard Murphy would temporarily take over. Guess it's proof that even having tons of money can't make things go smoothly.
More Woes for the Stem Cell Initiative In California
Sep 03, 2007